Skip to main content
. 2016 Jan 21;16:13. doi: 10.1186/s12887-016-0551-8

Table 3.

Brazilian license situation, indications for neonates and off–label use in neonates in Brazil

MICROMEDEX BNFC 2012–2013
n (%) Indicated (%) Not (%) NI (%) Indicated (%) Not (%) NI (%) Most frequent drugs (neonates)
Licensed 329 (19.1) 78.7 21.3 -- 75.4 24.6 -- domperidone (59)a,c, vancomycin (55), pulmonary surfactant (49), phytomenadione (47), furosemide (29), epinephrine (26)
Unlicensed 38 (2.2) 36.8 7.9 55.3 47.4 -- 52.6 tricalciumphosphate (18)b,d, alprostadil (2), biotin (2), L-carnitine (2), riboflavin (2), thiamine (2)
Off-label 1358 (78.7) 64.8 22.9 12.3 90.6 3.0 6.4
Age 869 (50.4) 55.6 33.0 11.4 87.8 2.8 9.4 heparin (97), fentanyl (92), multivitamins without minerals (91)b, aminophylline (87), ranitidine (53), metamizole (37)a,d, cefepime (31)a,d, omeprazole (29)a
Dose/frequency 345 (20.0) 82.9 1.7 15.4 98.8 1.2 -- gentamicin (110), ampicillin (108), amikacin (36), vancomycin (15), midazolam (3), ampicillin/sulbactam (5)
Age, pharmaceutical form 23 (1.3) 34.8 65.2 -- 95.7 4.3 -- spironolactone (7), methadone (6), captopril (3), propranolol (2), sildenafil (2)
Age, route of administration 29 (1.7) 48.3 -- 51.7 51.7 48.3 -- multivitamins without minerals (15)b, mineral oil (14)b,c
Route of administration 61 (3.5) 96.7 3.3 -- 96.7 3.3 -- phytomenadione (59), nystatin (2)a,c
Age, form, route of administration 14 (0.8) 100.0 -- -- 100.0 -- -- aminophylline (14)
Age, dose/frequency 8 (0.5) 100.0 -- -- 100.0 -- -- aminophylline (8)
Indication, pharmaceutical form, route of administration 6 (0.3) 100.0 -- -- 100.0 -- -- epinephrine (6)
Age, indication, pharmaceutical form 1 (0.1) 100.0 -- -- 100.0 -- -- acetylsalicylic acid (1)a
Dose/frequency, pharmaceutical form 2 (0.1) 100.0 -- -- 100.0 -- -- furosemide (1), levothyroxine (1)
Total 1725 (100.0) 66.8 22.3 10.9 86.8 7.1 6.1

NI No information

aNot indicated by Micromedex

bNot found in Micromedex

cNot indicated by BNFC

dNot found in BNFC